How obesity is affecting the UK and COVID-19 mortality in patients

Written by: Dr Mark Vanderpump
Published:
Edited by: Sarah Sherlock

Recently, we spoke with experienced endocrinologist Dr Mark Vanderpump on the effects of obesity on COVID-19 and here is what he shared.

 

obesity and covid

 

Earlier in the year, a minister’s comment about the link between a high COVID death toll and obesity in the UK was poorly received, but it’s a fact that obesity and its associated medical conditions (such as diabetes and heart disease) have long been considered one of our biggest health challenges.

 

Indeed, prior to the pandemic we already knew that obesity is a risk factor and predictor of serious disease generally and, through extensive global research, this has also proved to be the case regarding COVID-19.

 

This research looked into which people are at the greatest risk of developing severe COVID-19, or of the virus causing their mortality. Again and again obesity proved to be a greater risk of:

 

  • infection
  • hospitalisation
  • clinically severe disease
  • mechanical ventilation
  • ICU admission
  • mortality

 

 

The growing problem of obesity in the UK

In 2018, a House of Commons Briefing paper revealed that 31 per cent of the nation’s women were overweight and 30 per cent were obese, while 40 per cent of men were overweight and 27 per cent were obese.

 

Adult obesity in the UK rose from 15 per cent to 29 per cent between 1993 and 2017, with people aged 45 and over making up 70 per cent of the overweight/obese population.

 

During the pandemic, like medical organisations in many other countries, NHS England examined its patients records in the hope of identifying any common factors possibly associated with COVID-19 related deaths in hospital. As a result, they stated two main reasons for an apparent connection between obesity and dying from COVID-19:

 

  1. Someone who has a higher bodyweight will have a reduced lung capacity, which causes respiratory problems, which in turn, can be exacerbated by COVID-19.
  2. Obesity increases the risk of such vulnerable underlying conditions such as heart disease, respiratory disease, and diabetes.

 

 

The PREVAIL programme

Even when we know we need to lose weight, we often don’t succeed. So, in 2019, the University of Oxford examined why those who were dieting were often condemned to failure. What was found is that the people who weighed themselves regularly were more likely to lower their weight as opposed to those who did not weigh themselves regularly.

 

This success was attributed to self-regulation and a DIY diet. There were 53 actions that were finalised as part of the PREVAIL programme.

 

Only half of the 100 people who took part in the first programme weighed themselves daily, and also only half chose at least one daily action from the list, despite the fact there was no upper limit.

 

Those who had adopted these daily habits during the eight weeks lost half a stone/3.2kg more than those who hadn’t.

 

 

The 53 PREVAIL programme actions

This list of self-regulating actions may be helpful for those who have struggled to lose weight.

 

10 weightloss actions

 

 

If you have been struggling with losing weight, struggle with diabetes, or would like more information, you can go to Dr Vanderpump's profile and schedule a consultation.

By Dr Mark Vanderpump
Endocrinology, diabetes & metabolism

Dr Mark Vanderpump is a highly experienced consultant endocrinologist based in London who specialises in adrenal gland disorders, hyperparathyroidism and hyperthyroidism alongside hypothyroidism, thyroid disorders and diabetes. Furthermore he has significant expertise in treating polycystic ovaries (PCOS). He practices at The Physicians' Clinic, Wellington Diagnostics & Outpatients Centre and One Welbeck Digestive Health clinic.

Dr Vanderpump has had a career spanning over 30 years, and was previously a consultant physician and honorary senior lecturer in endocrinology and diabetes at the Royal Free London NHS Foundation Trust. His main area of expertise is thyroid disease, but his clinical practice includes all aspects of diabetes and endocrinology. He also sees referrals of less frequently-occurring conditions such as thyroid cancer; pituitary conditions such as acromegaly; and adrenal disorders including Addison's disease, plus calcium and bone disorders.

Dr Vanderpump, who is highly qualified with an MBChB, MRCP and MD alongside a CCST and FRCP, did higher training in the West Midlands, North East England and North Staffordshire.

Dr Vanderpump is a respected figurehead in the endocrinology community. He is the former president of the British Thyroid Association and former chair of the London Consultants' Association.

He continues to lecture on diabetes and thyroid disease, is widely published in peer-reviewed journals and has published a book called Thyroid Disease (The Facts). He is also a member of the Royal College of Physicians (RCP), where he is also a fellow, the British Thyroid Association (BTA) and the Society of Endocrinology (SoE). Furthermore, he has professional membership of the Association of British Clinical Diabetologists (ABCD) , London Consultants' Association and the Independent Doctors Federation.   
 

View Profile

Overall assessment of their patients


  • Related procedures
  • Alopecia
    Hyperhidrosis
    Eating disorders
    Erectile dysfunction
    Menopause
    Polycystic ovary syndrome (PCOS)
    Hypertension (high blood pressure)
    Infertility
    Disorder of sexual desire of man
    Clinical nutrition
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.